CF PharmTech Inc

CF PharmTech, Inc. is a China-based company engaged in the research, development, production, and sale of respiratory drugs and related medical products. Its offerings include Shufeimin, an azelastine hydrochloride and fluticasone propionate nasal spray; ChangQi, a budesonide inhalation suspension; ChangShu, a salbutamol sulfate inhalation solution; and a piezoelectric mesh nebulizer, electric nasal cleaner, and BFS hypertonic and physiological seawater nasal cleansing fluids under the ChangShu name. The company also develops treatments for respiratory diseases such as allergic rhinitis, asthma, chronic obstructive pulmonary disease, respiratory infections, pulmonary fibrosis, and pulmonary hypertension, as well as inhalation sprays and aerosols, dry powder inhalers, nebulization and nasal spray products, and liposomes. In addition, it provides CDMO/CMO technical services. Formerly known as Suzhou CF PharmTech Co., Ltd., the company was founded in 2007 and is based in Suzhou, China.